Sensorion is currently owned by Sofinnova Partners, through Sofinnova Crossover Fund I, since 2018.

When did Sofinnova Partners acquire Sensorion?

Sofinnova Partners acquired Sensorion in 2018 (active for 8 years).

Sensorion

Biotech·

France·Active·8yr hold

Sensorion is a healthcare / biotech company, headquartered in France.

Entry

2018

Hold

8yr

Status

Active

Est. EV

–

Investor

HQFrance

SectorHealthcare / Biotech

French clinical biopharmaceutical company developing gene therapy and small molecule treatments for inner ear disorders.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Sofinnova Crossover Fund I

6 comparable biotech deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings